Skip to main content
. 2021 Jan 1;11(4):1690–1702. doi: 10.7150/thno.53691

Figure 3.

Figure 3

Number of candidates of SARS-CoV-2 vaccines by phase of clinical trial. As of November 04, 2020, fifty-two vaccines against SARS-CoV-2 are undergoing clinical trials, including 22 in Phase 1, 18 in Phase 1/2, three in Phase 2, and 9 in Phase 3.